Viewing StudyNCT03208218



Ignite Creation Date: 2024-05-06 @ 10:15 AM
Last Modification Date: 2024-10-26 @ 12:27 PM
Study NCT ID: NCT03208218
Status: COMPLETED
Last Update Posted: 2017-07-06
First Post: 2017-06-25

Brief Title: Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers
Sponsor: Samyang Biopharmaceuticals Corporation
Organization: Samyang Biopharmaceuticals Corporation

Organization Data

Organization: Samyang Biopharmaceuticals Corporation
Class: INDUSTRY
Study ID: BIBE2016-02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Samyang Biopharmaceuticals Corporation
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Chungnam National University Hospital OTHER